Suraksha Diagnostic Reports Strong FY26 Performance, Recommends Dividend

Suraksha Diagnostic Limited's Board of Directors met on May 21, 2026, to approve the audited financial results for the fiscal year ending March 31, 2026. The company announced a consolidated profit after tax of ₹61.60 crore and a standalone profit after tax of ₹57.06 crore.

Dividend Approval and AGM

The board recommended a dividend of ₹0.50 per equity share, totaling 25% of the face value, for the financial year 2025-26. This recommendation is subject to the approval of shareholders at the upcoming 21st Annual General Meeting (AGM). The AGM is scheduled for September 2, 2026, and will be conducted via video conference.

Financial Performance Highlights

For the financial year ended March 31, 2026, Suraksha Diagnostic reported:

• Consolidated Revenue: ₹82.20 crore
• Consolidated Profit After Tax: ₹61.60 crore
• Standalone Revenue: ₹79.86 crore
• Standalone Profit After Tax: ₹57.06 crore

As of March 31, 2026, the company's consolidated assets stood at ₹448.12 crore, with consolidated liabilities at ₹204.64 crore. Standalone assets were ₹450.14 crore, and standalone liabilities were ₹200.34 crore.

Corporate Governance Appointments

The company also approved the notice for the AGM and made key appointments. M/s. Suresh Surana & Associates LLP has been appointed as the Internal Auditor for FY26-27. Additionally, M/s. S Chhaparia & Associates has been re-appointed as the Cost Auditor for the same fiscal year. Both appointments are subject to shareholder ratification.

Subsidiary Dispute and Risk Assessment

Suraksha Diagnostic is facing a significant challenge due to a dispute with the Government of Meghalaya, which has led to operational losses for one of its step-down subsidiaries. The recoverability of ₹392.20 lakh in investments, loans, and trade receivables related to this subsidiary is currently under assessment. Management is actively pursuing arbitration to resolve the matter.

What Investors Should Watch

Shareholders will vote on the proposed dividend at the upcoming AGM. Investors are also advised to closely monitor the progress and outcome of the arbitration proceedings concerning the subsidiary dispute, as it represents a key risk factor for the company.